The Parkinson's disease gene PINK1 activates Akt via PINK1 kinase-dependent regulation of the phospholipid PI(3,4,5)P3

被引:27
|
作者
Furlong, Rachel M. [1 ,2 ,3 ]
Lindsay, Andrew [1 ]
Anderson, Karen E. [4 ]
Hawkins, Phillip T. [4 ]
Sullivan, Aideen M. [2 ,3 ]
O'Neill, Cora [1 ,3 ]
机构
[1] Univ Coll Cork, Sch Biochem & Cell Biol, Biosci Inst, Cork T12 YT20, Ireland
[2] Univ Coll Cork, Dept Anat & Neurosci, Western Gateway Bldg, Cork T12 XF62, Ireland
[3] Univ Coll Cork, Cork NeuroSci Ctr, Cork T12 YT20, Ireland
[4] Babraham Inst, Signalling Programme, Cambridge CB22 3AT, England
基金
英国生物技术与生命科学研究理事会;
关键词
Akt; Parkinson's disease; PINK1; neurodegeneration; PIP3; 3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE-1; GOLGI FRAGMENTATION; TUMOR-SUPPRESSOR; MITOCHONDRIAL DEPOLARIZATION; RECEPTOR TRAFFICKING; POSITIVE REGULATION; OXIDATIVE STRESS; SAC1; DOMAIN; CELL-DEATH; PHOSPHORYLATION;
D O I
10.1242/jcs.233221
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Akt signalling is central to cell survival, metabolism, protein and lipid homeostasis, and is impaired in Parkinson's disease (PD). Akt activation is reduced in the brain in PD, and by many PD-causing genes, including PINK1. This study investigated the mechanisms by which PINK1 regulates Akt signalling. Our results reveal for the first time that PINK1 constitutively activates Akt in a PINK1-kinase dependent manner in the absence of growth factors, and enhances Akt activation in normal growth medium. In PINK1-modified MEFs, agonist-induced Akt signalling failed in the absence of PINK1, due to PINK1 kinase-dependent increases in PI(3,4,5)P-3 at both plasma membrane and Golgi being significantly impaired. In the absence of PINK1, PI(3,4,5)P-3 levels did not increase in the Golgi, and there was significant Golgi fragmentation, a recognised characteristic of PD neuropathology. PINK1 kinase activity protected the Golgi from fragmentation in an Akt-dependent fashion. This study demonstrates a new role for PINK1 as a primary upstream activator of Akt via PINK1 kinase-dependent regulation of its primary activator PI(3,4,5)P-3, providing novel mechanistic information on how loss of PINK1 impairs Akt signalling in PD. This article has an associated First Person interview with the first author of the paper.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] The Anthelmintic Drug Niclosamide and Its Analogues Activate the Parkinson's Disease Associated Protein Kinase PINK1
    Barini, Erica
    Miccoli, Ageo
    Tinarelli, Federico
    Mulholland, Katie
    Kadri, Hachemi
    Khanim, Farhat
    Stojanovski, Laste
    Read, Kevin D.
    Burness, Kerry
    Blow, Julian J.
    Mehellou, Youcef
    Muqit, Miratul M. K.
    CHEMBIOCHEM, 2018, 19 (05) : 425 - 429
  • [22] LRRK2 impairs PINK1/Parkin-dependent mitophagy via its kinase activity: pathologic insights into Parkinson's disease
    Bonello, Fiona
    Hassoun, Sidi-Mohamed
    Mouton-Liger, Francois
    Shin, Yea Seul
    Muscat, Adeline
    Tesson, Christelle
    Lesage, Suzanne
    Beart, Philip M.
    Brice, Alexis
    Krupp, Johannes
    Corvol, Jean-Christophe
    Corti, Olga
    HUMAN MOLECULAR GENETICS, 2019, 28 (10) : 1645 - 1660
  • [23] Endomembrane PtdIns(3,4,5)P3 activates the PI3K-Akt pathway
    Jethwa, Nirmal
    Chung, Gary H. C.
    Lete, Marta G.
    Alonso, Alicia
    Byrne, Richard D.
    Calleja, Veronique
    Larijani, Banafshe
    JOURNAL OF CELL SCIENCE, 2015, 128 (18) : 3456 - 3465
  • [24] Loss of Non-Apoptotic Role of Caspase-3 in the PINK1 Mouse Model of Parkinson's Disease
    Imbriani, Paola
    Tassone, Annalisa
    Meringolo, Maria
    Ponterio, Giulia
    Madeo, Graziella
    Pisani, Antonio
    Bonsi, Paola
    Martella, Giuseppina
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (14)
  • [25] Phosphorylation of parkin by Parkinson disease-linked kinase PINK1 activates parkin E3 ligase function and NF-κB signaling
    Sha, Di
    Chin, Lih-Shen
    Li, Lian
    HUMAN MOLECULAR GENETICS, 2010, 19 (02) : 352 - 363
  • [26] Heterozygous PINK1 p.G411S mutation increases risk for Parkinson's disease (PD)
    Springer, W.
    Puschmann, A.
    Fiesel, F. C.
    Ando, M.
    Caulfield, T. R.
    Ogaki, K.
    Heckman, M. G.
    Hudec, R.
    James, E. D.
    Opala, G.
    Siuda, J.
    Boczarska-Jedynak, M.
    Friedman, A.
    Koziorowski, D.
    Aasly, J. O.
    Lynch, T.
    Mellick, G. D.
    Mohan, M.
    Silburn, P. A.
    Sanotsky, Y.
    Vilarino-Guell, C.
    Farrer, M. J.
    Dawson, T.
    Wszolek, Z. K.
    Ross, O. A.
    MOVEMENT DISORDERS, 2016, 31 : S282 - S282
  • [27] Mechanisms of activation and substrate recognition by PINK1, a ubiquitin kinase implicated in mitochondrial quality control and Parkinson's disease
    Trempe, Jean-Francois
    PROTEIN SCIENCE, 2017, 26 : 94 - 94
  • [28] Discovery of catalytically active orthologues of the Parkinson's disease kinase PINK1: analysis of substrate specificity and impact of mutations
    Woodroof, Helen I.
    Pogson, Joe H.
    Begley, Mike
    Cantley, Lewis C.
    Deak, Maria
    Campbell, David G.
    van Aalten, Daan M. F.
    Whitworth, Alexander J.
    Alessi, Dario R.
    Muqit, Miratul M. K.
    OPEN BIOLOGY, 2011, 1
  • [29] Parkinson's Disease-Associated Kinase PINK1 Regulates Miro Protein Level and Axonal Transport of Mitochondria
    Liu, Song
    Sawada, Tomoyo
    Lee, Seongsoo
    Yu, Wendou
    Silverio, George
    Alapatt, Philomena
    Millan, Ivan
    Shen, Alice
    Saxton, William
    Kanao, Tomoko
    Takahashi, Ryosuke
    Hattori, Nobutaka
    Imai, Yuzuru
    Lu, Bingwei
    PLOS GENETICS, 2012, 8 (03):
  • [30] PINK1 p.K520RfsX3 mutation identified in a Chinese family with early-onset Parkinson's disease
    Wang, Peng
    Guo, Yi
    Song, Chengyuan
    Liu, Yiming
    Deng, Hao
    NEUROSCIENCE LETTERS, 2018, 676 : 98 - 102